Red Tortoise LLC’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168 | Hold |
150
| – | – | ﹤0.01% | 583 |
|
|
2025
Q1 | $146 | Hold |
150
| – | – | ﹤0.01% | 568 |
|
|
2024
Q4 | $176 | Hold |
150
| – | – | ﹤0.01% | 580 |
|
|
2024
Q3 | $252 | Hold |
150
| – | – | ﹤0.01% | 558 |
|
|
2024
Q2 | $213 | Hold |
150
| – | – | ﹤0.01% | 567 |
|
|
2024
Q1 | $569 | Hold |
150
| – | – | ﹤0.01% | 546 |
|
|
2023
Q4 | $405 | Hold |
150
| – | – | ﹤0.01% | 518 |
|
|
2023
Q3 | $237 | Hold |
150
| – | – | ﹤0.01% | 541 |
|
|
2023
Q2 | $394 | Hold |
150
| – | – | ﹤0.01% | 536 |
|
|
2023
Q1 | $546 | Hold |
150
| – | – | ﹤0.01% | 545 |
|
|
2022
Q4 | $591 | Buy |
+150
| New | +$591 | ﹤0.01% | 568 |
|
|
2021
Q4 | – | Sell |
-150
| Closed | -$1K | – | 219 |
|
|
2021
Q3 | $1K | Buy |
+150
| New | +$1K | ﹤0.01% | 498 |
|